Predictive Factors for the Success of Vaginal Dinoprostone for the Induction of Labour
DOI: https://doi.org/10.2147/ijwh.s461094
2024-06-14
International Journal of Women s Health
Abstract:Wenjie Liu, Li Guo, Lizhen Feng, Jie Wang, Miao Zhang, Xiaobin Fan Department of Obstetrics and Gynecology, Xi'an No.3 Hospital, The Affiliated Hospital of Northwest University, Xi'an, 710018, People's Republic of China Correspondence: Xiaobin Fan, Email Objective: To evaluate factors predictive of the success of a slow-release dinoprostone vaginal insert for cervical ripening. Methods: This retrospective study included 187 women who received dinoprostone vaginal inserts for cervical ripening. The participants were divided into two groups: the transvaginal delivery group (n = 87) and cesarean section termination group (n = 100). The correlation between the parameters present before cervical ripening with dinoprostone slow release and its success, as well as complications and adverse outcomes, was analyzed. Cesarean section predictors and area under the curve (AUC) were compared between the two Groups. Results: There were statistical differences between the two groups in body mass index (BMI), height, cervical Bishop score, cephalic position, time of medication use, and fetal head position at the time of medication use ( P < 0.05). The optimal thresholds for identifying cesarean section in dinoprostone vaginal insert for cervical ripening were 162.5 for height (AUC = 0.61), 10.65 cm for amniotic fluid index (AUC = 0.6), S-2.5 for cephalic position (AUC = 0.61), 5.5 for bishop score of cervix (AUC = 0.65). The height, amniotic fluid index, cephalic position, and Bishop score of the cervix were included in the same model. The AUC value of the combined model was higher than the AUC value of the single factor. Conclusion: The combined model was a better predictor of cesarean section in dinoprostone vaginal inserts for cervical ripening and labor induction. The success of cervical ripening with a dinoprostone slow-release vaginal insert can be predicted by the factors that can be recognized at admission. Keywords: dinoprostone, cervical ripening, labor induction, predictive model During labor, the cervix should soften and dilate to allow the fetus to pass through the birth canal. The process by which the cervix becomes soft and partially dilated is called "cervical ripening". 1 Cervical ripening is believed to result from a combination of biochemical, endocrine, and mechanical events. When there are indications of labor induction and the cervix is in unfavorable conditions, agents for cervical maturation may be used, thus reducing induced labor time. 2,3 Induced labor refers to the process of causing uterine contractions through medical or surgical means before spontaneous delivery begins. 4 It is a widely used method for full-term delivery, accounting for 25% of pregnancies. 5 Indications for induced labor included absence of labor at 41 weeks, gestational diabetes, premature rupture of membranes, and reduced amniotic fluid. Cervical ripeness was assessed using the Bishop scoring system, with a Bishop score of ≤6 indicating an immature cervix. 6 Cervical ripening may be required if the cervix is immature before induction. The medications used for cervical ripening include prostaglandins, misoprostol, and oxytocin. 7 The use of misoprostol tablets for vaginal administration is uncertain owing to its specific characteristics, and misoprostol cannot be retrieved from the vagina in cases of maternal-fetal complications. Therefore, its clinical use is currently limited. 8 In pregnant women with an immature cervix, the failure rate of cervical ripening with oxytocin was relatively high. Oxytocin induction was prioritized when the Bishop score was > 6, oxytocin induction is prioritized. 9 Prostaglandins act on the cervix through various mechanisms to promote cervical ripening. 10,11 Based on years of research and improvement, dinoprostone is a prostaglandin analog. Dinoprostone vaginal suppositories (trade name: Cervidil) are synthetic preparations, chemically and structurally identical to prostaglandin E2 (PGE2). It acts as an oxytocic. 12–14 Cervidil is designed to provide constant and sustained release of PGE2 to the cervix to promote cervical ripening, with the main advantage of being removable during labor or in case of adverse reactions, compared to other prostaglandins. It has been shown to be safe and effective for pregnant women and fetuses. 15,16 However, the probability of vaginal delivery after dinoprostone placement is still relatively low, and some cases may still require cesarean section after cervical ripening and induction to terminate the pregnancy. However, the exact reason is not provided in the text. The Bishop score indicates changes in the cervical response to delivery, which can affect th -Abstract Truncated-
obstetrics & gynecology